Genetics of Cardiovascular Diseases Consortium Opens at HSE University
The Genetics of Cardiovascular Diseases Consortium, the first of this kind in Russia, was unveiled at HSE University at Cardiogenetics and Bioinformatics: 2021 Realities, an interdisciplinary forum. The consortium aims to compile a centralized and complete catalogue of the Russian population’s genomic mutations..
Research has shown that various demographics have their own genetic mutations. The Genetics of Cardiovascular Diseases Consortium aligns the effort of various research groups and institutions to investigate the genetics of cardiovascular diseases (CVDs), which have been among the leading causes of death around the world for some time. The consortium’s activities are aimed at facilitating the choice of therapy that would take into account individual mutations and better personalize treatment.
Creating a centralized and complete catalogue of the Russian population’s genomic mutations is necessary for improving diagnostics and treatment of CVDs. The goal of the Consortium is to collect a nationwide catalogue of these mutations, develop and apply it in medical practice, and in the future, to create special user services for the process.
The last two decades have shown that genetic foundation is important and, in some cases, even critical for making treatment decisions: the same treatment may bring benefit to one patient, harm another patient, and do nothing for yet another patient. Experienced multidisciplinary teams are needed to choose the proper therapy for a specific person that would take into account their genetics. The consortium brings such experts together and offers a platform for creating new teams in cardiogenetics
The list of consortium participants is available here.
Researchers at the Institute of Cognitive Neuroscience of the Higher School of Economics have proposed to train transplanted muscles in advance with new movements so that the brain can learn to use them more quickly after autotransplantation. The results of the study on the prospects of this approach were published in the article ‘Perspectives for the Use of Neurotechnologies in Conjunction with Muscle Autotransplantation in Children’.
Scientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Sciences (IBCh RAS), and the Memorial Sloan Kettering Cancer Center created a genetic model that helps to understand how the body restrains autoimmune and oncological diseases. The researchers published their results in Nature Immunology.
It’s impossible to imagine modern medicine without engineering and computer solutions. The HSE Master's programme ‘System and Software engineering’ deals with the development of such innovations. 2018 graduate, Alexandra Gureeva, talks about her project focusing on electronic medical records and which has already been tested at a Moscow clinic.
The markets for healing and witch doctors are often developed in smaller cities and also serve nearby rural areas as well. Such centres of 'informal healthcare' most commonly thrive among individuals who have become disappointed with traditional medicine or among those who do not have access to traditional medicine, Yulia Krasheninnikova, Associate Professor in the Faculty of Management’s Department of State and Municipal Management at HSE Perm campus, said in the study 'Beyond the Healthcare System: The Development of Alternative Health Services in Urban and Rural Areas.'
Over the course of 20 years, since the beginning of contemporary medicine’s transition into a digital format, a vast amount of largely unused data has amassed. The analysis of these data and the extraction of a new logic of control from them is one of the most popular areas of focus in applied mathematics, Oleg Pianykh, Professor in HSE’s Department of Data Analysis and Artificial Intelligence and an Associate Professor at Harvard Medical School, said in a report. His report, 'Big Data in Medicine: How to Make them Work,' was presented at HSE’s academic seminar 'Mathematical Models of Information Technologies.'
Russia will better be able to treat cancer, tuberculosis, HIV, strokes and heart attacks if it develops its own success stories in several medical fields of the future. Firstly, it is necessary to improve regenerative medicine, biomedicine, genomic research, the production of medicines that target specific health problems, and molecular diagnostics. It will otherwise be difficult to increase the life expectancy in the country and strengthen Russia’s position on the world market for medical technologies, Alexander Chulok says in an article published in HSE’s journal Foresight, 7(3), for 2013.